A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18

Liver International

Volumn 35, Issue 1, 2015, Pages 184-191

  Biselli, Maurizio ^a   Dall'Agata, Marco ^a   Gramenzi, Annagiulia ^a   Gitto, Stefano ^b   Liberati, Caterina ^c   Brodosi, Lucia ^a   Ravaioli, Matteo ^a   Gambato, Martina ^d   Montalti, Roberto ^b   Pinna, Antonio D ^a   Burra, Patrizia ^d   Gerunda, Giorgio E ^b   Cillo, Umberto ^d   Andreone, Pietro ^a   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Competing risk; Liver transplantation; Organ allocation; Prognosis; Scoring system; Survival analysis; Wait list

Indexed keywords

ALBUMIN; BILIRUBIN; SODIUM; SERUM ALBUMIN;

ADULT; ADVERSE OUTCOME; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASSESSMENT OF HUMANS; BILIRUBIN BLOOD LEVEL; CHILD PUGH SCORE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSMER LEMESHOW TEST; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER RENAL RISK CONCORDANCE INDEX; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OUTCOME ASSESSMENT; PATIENT DROPOUTS; PREDICTIVE VALIDITY; PREDICTIVE VALUE; PROGNOSTIC ASSESSMENT; RISK ASSESSMENT; SCORING SYSTEM; SODIUM BLOOD LEVEL; SURVIVAL; BLOOD; COHORT ANALYSIS; COMPLICATION; END STAGE LIVER DISEASE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STANDARDS; THEORETICAL MODEL; VALIDATION STUDY;

ASCITES; BILIRUBIN; COHORT STUDIES; END STAGE LIVER DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SODIUM; WAITING LISTS;

EID: 84921022056     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12538     Document Type: Article

References (31)

1. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
2. Wiesner RH, McDiarmid SW, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-80.
3. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
4. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-13.
5. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation 1998; 66: 956-62.
6. Dawwas MF, Gimson AE. Candidate selection and organ allocation in liver transplantation. Semin Liver Dis 2009; 29: 40-52.
7. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
8. Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008; 57: 1156-65.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
10. Heuman DM, Abou-assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802-10.
11. Kim WR, Biggins SW, Kremers W, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.
12. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26: 2389-430.
13. Wolbers M, Koller MT, Witteman JCM, Steyerberg EW. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 2009; 20: 555-61.
14. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982; 115: 92-106.
15. Kim WR, Therneau TM, Benson JT, et al. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2006; 43: 345-51.
16. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-54.
17. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009. ISBN 3-900051-07-0. Available at http://www.R-project.org. Accessed: November 2013.
18. Bronsther O, Fung JJ, Van Thiel D, Starzl TE. Prioritization and organ distribution for liver transplantation. JAMA 1994; 271: 140-3.
19. Austin MT, Poulose BK, Ray WA, et al. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg 2007; 142: 1079-85.
20. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, neuropsychometric testing, and ascites. Am J Gastroenterol 2003; 98: 1395-9.
21. Huo TI, Lin HC, Wu JC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006; 20: 188-94.
22. Berg CL, Steffick DE, Edwards EB, et al. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009; 9: 907-31.
23. Cholongitas E, Shusang V, Marelli L, et al. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther 2007; 26: 969-78.
24. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores-A systematic bias. Am J Transpl 2007; 7: 685-92.
25. Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 1987; 82: 945-52.
26. Gonwa TA, Jennings L, Mai ML, et al. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301-9.
27. MacAulay J, Thompson K, Kiberd BA, Barnes DC, Peltekian KM. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? Can J Gastroenterol 2006; 20: 521-6.
28. Biselli M, Gitto S, Gramenzi A, et al. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? Liver Transpl 2010; 16: 964-73.
29. Olthoff KM, Brown RS Jr, Delmonico FL, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD Era. Liver Transpl 2004; 10: A6-22.
30. Kim WR, Stock PG, Smith JM, et al. OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant 2013; 13(Suppl. 1): 73-102.
31. Toso C, Dupuis-Lozeron E, Majno P, et al. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list. Hepatology 2012; 56: 149-56.